$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
苯达莫司汀的疗效好吗?长期用苯达莫司汀会有哪些副作用
2025-10-19 11:44:20
Check Details
进一步探索Zilovertamab + 伊布替尼用于复发/难治性MCL
2025-10-19 11:44:20
Check Details
FDA授予C-CAR039治疗复发/难治性DLBCL的再生医学先进疗法和快速通道指定
2025-10-19 11:44:20
Check Details
他泽司他tazemetostat用于治疗复发/难治性滤泡性淋巴瘤
2025-10-19 11:44:20
Check Details
他泽司他多少钱一盒?哪里有便宜的他泽司他
2025-10-19 11:44:20
Check Details
新一代造血干细胞动员剂:普乐沙福
2025-10-19 11:44:20
Check Details
赛诺菲强效动员剂普乐沙福中国获批
2025-10-19 11:44:20
Check Details
CAR-T治疗——倍诺达从ASH进展到临床应用
2025-10-19 11:44:20
Check Details
使用奈拉宾时应注意哪些事项?
2025-10-19 11:44:20
Check Details
使用奈拉宾的这些事项需要严格注意!
2025-10-19 11:44:20
Check Details
什么?利妥昔单抗也可以治疗免疫性疱病吗?
2025-10-19 11:44:20
Check Details
重磅!达伯华(利妥昔单抗注射液)在中国正式获批上市
2025-10-19 11:44:20
Check Details
1
2
...
1269
1270
1271
1272
1273
1274
1275
...
4162
4163
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Tucatinib Plus Trastuzumab and Pertuzumab Maintenance in HER2-Positive Advanced Breast Cancer: HER2CLIMB-05 Median PFS 24.9 Months
2
Zenocutuzumab (Bizengri) for NRG1 Fusion Solid Tumors: HER2×HER3 Bispecific, 750mg Q2W, NSCLC/Pancreas/Cholangiocarcinoma
3
Pemigatinib for FGFR2 Cholangiocarcinoma and FGFR1 Hematologic Use: First-Line Data, 21-Day Dosing, Phosphate and Ocular Management
4
Dabrafenib (Tafinlar) Complete Guide: Indications, Dosing, Combination Therapy and Safety
5
Binimetinib plus Encorafenib for BRAF‑Mutant Melanoma
6
Adagrasib (Krazati) for KRAS G12C: NSCLC Dosing, Titration, and CRC Regulatory Update
7
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
8
Enzalutamide for Prostate Cancer: Managing Fatigue, Dizziness, Hypertension, and Serious Neurocardiovascular Risks
9
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
10
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance
11
Lorlatinib Contraindications and Safety Warnings: Six Key Risks to Monitor
12
Dacomitinib for EGFR-Mutant NSCLC: Dosing, Switching, and Safety Profile